ArticleCancers2023
ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma.
Open access · goldAbstract read
In one paragraph
Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 16 citations in OpenAlex.
- Cancer-Associated Fibroblast-Derived FGF7 Promotes Immune Escape in Oral Squamous Cell Carcinoma via JAK/STAT3-Mediated PD-L1 Expression.Molecular carcinogenesis · 2026Article
- Aortic carboxypeptidase-like protein potentiates β1 integrin signaling in mesenchymal progenitors.Life science alliance · 2026Article
- Nanomaterials targeting cancer-associated fibroblasts to overcome stromal barriers in cancer immunotherapy.Journal of nanobiotechnology · 2026Review
- In vitro models of cancer-associated fibroblast heterogeneity uncover subtype-specific effects of CRISPR perturbations.Molecular oncology · 2026Article
- Elucidating the Predominant Role of AEBP1 in Different Types of Cancers with a Focus on Glioblastoma Progression - A Review.Current gene therapy · 2026Review
- Pan-Cancer Analysis Reveals AEBP1-Collagen Co-Expression and Its Potential Role in CAF-Mediated Tumor Stiffness.International journal of molecular sciences · 2025Article
- AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.Nature communications · 2025Article
- Immune Microenvironment in Oral Potentially Malignant Disorders and Oral Cancer: A Narrative Review.International journal of molecular sciences · 2025Review
- Investigating the potential role of EIF2S2 in OSCC progression through comprehensive bioinformatics analysis and experimental validation.European journal of medical research · 2025Article
- Effects of FAP+ fibroblasts on cell proliferation migration and immunoregulation of esophageal squamous carcinoma cells through the CXCL12/CXCR4 axis.Molecular and cellular biochemistry · 2025Article
- Desmoglein-2 was a novel cancer-associated fibroblasts-related biomarker for oral squamous cell carcinoma.BMC oral health · 2025Article
- Molecular insights into immune evasion in head and neck squamous cell carcinomas: Toward a promising treatment strategy.Oncology research · 2025Review
- AEBP1 is a negative regulator of skeletal muscle cell differentiation in oral squamous cell carcinoma.Scientific reports · 2024Article
- Tumor microenvironment in oral squamous cell carcinoma.Frontiers in immunology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 2 institutions in 1 country.
Shohei SekiguchiDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Akira YorozuDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Fumika OkazakiDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Takeshi NiinumaDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Akira TakasawaDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Eiichiro YamamotoDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Hiroshi KitajimaDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Toshiyuki KuboDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Yui HatanakaDepartment of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Koyo NishiyamaDepartment of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Kazuhiro OgiDepartment of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Hironari DehariDepartment of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Atsushi KondoDepartment of Head and Neck Oncology, Sapporo Teishinkai Hospital, Sapporo 065-0033, Japan.
Makoto KuroseDepartment of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Kazufumi ObataDepartment of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Akito KakiuchiDepartment of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Masahiro KaiDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Yoshihiko HirohashiDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.ORCID 0000-0002-0608-3914
Toshihiko TorigoeDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.ORCID 0000-0002-9463-5917
Takashi KojimaDepartment of Cell Science, Research Institute of Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.ORCID 0000-0002-6346-4588
Makoto OsanaiDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Kenichi TakanoDepartment of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.ORCID 0000-0001-8706-6384
Akihiro MiyazakiDepartment of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.ORCID 0000-0003-3290-6205
Hiromu SuzukiDepartment of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.ORCID 0000-0001-9635-3238
Sapporo Medical University · JPKeiyukai Sapporo Hospital · JP
Funding
Japan Society for the Promotion of Science JSPS KAKENHI 20K08335Japan Society for the Promotion of Science JSPS KAKENHI 21K07985Japan Society for the Promotion of Science JSPS KAKENHI 21K16846Japan Society for the Promotion of Science JSPS KAKENHI 22H02925Sapporo Jikeikai Tomoiki Foundation 2022
Abstract
We previously showed that upregulation of adipocyte enhancer-binding protein 1 (
Indexed as
cancer-associated fibroblastcollagenoral cancertumor-infiltrating lymphocytetumor microenvironment
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.